CCT6A
T-complex protein 1 subunit zeta
Also known as: CCT6, Cctz, HTR3, TCP20, TCPZ, TCPZ_HUMAN, TTCP20
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P40227
- Gene
- CCT6A
- Ensembl
- ENSG00000146731
- Chromosome
- 7
- Canonical length
- 531 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a molecular chaperone that is a member of the chaperonin containing TCP1 complex (CCT), also known as the TCP1 ring complex (TRiC). This complex consists of two identical stacked rings, each containing eight different proteins. Unfolded polypeptides enter the central cavity of the complex and are folded in an ATP-dependent manner. The complex folds various proteins, including actin and tubulin. Alternate transcriptional splice variants of this gene, encoding different isoforms, have been characterized. In addition, several pseudogenes of this gene have been located. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
531 residues, UniProt reviewed canonical sequence.
>P40227|CCT6A
1 MAAVKTLNPK AEVARAQAAL AVNISAARGL QDVLRTNLGP KGTMKMLVSG AGDIKLTKDG
61 NVLLHEMQIQ HPTASLIAKV ATAQDDITGD GTTSNVLIIG ELLKQADLYI SEGLHPRIIT
121 EGFEAAKEKA LQFLEEVKVS REMDRETLID VARTSLRTKV HAELADVLTE AVVDSILAIK
181 KQDEPIDLFM IEIMEMKHKS ETDTSLIRGL VLDHGARHPD MKKRVEDAYI LTCNVSLEYE
241 KTEVNSGFFY KSAEEREKLV KAERKFIEDR VKKIIELKRK VCGDSDKGFV VINQKGIDPF
301 SLDALSKEGI VALRRAKRRN MERLTLACGG VALNSFDDLS PDCLGHAGLV YEYTLGEEKF
361 TFIEKCNNPR SVTLLIKGPN KHTLTQIKDA VRDGLRAVKN AIDDGCVVPG AGAVEVAMAE
421 ALIKHKPSVK GRAQLGVQAF ADALLIIPKV LAQNSGFDLQ ETLVKIQAEH SESGQLVGVD
481 LNTGEPMVAA EVGVWDNYCV KKQLLHSCTV IATNILLVDE IMRAGMSSLK GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCT6A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 125 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 125 nTPM
- tongue: 81 nTPM
- tonsil: 77 nTPM
- esophagus: 70 nTPM
- kidney: 68 nTPM
- urinary bladder: 68 nTPM
Single-cell type
- esophageal basal cells: 338 nCPM
- erythrocyte progenitors: 315 nCPM
- differentiating spermatogonia: 303 nCPM
- esophageal suprabasal cells: 299 nCPM
- migrating cytotrophoblasts: 292 nCPM
- gastric progenitor cells: 291 nCPM
Immune cell
- non-classical monocyte: 104 nTPM
- myeloid DC: 97 nTPM
- intermediate monocyte: 88 nTPM
- total PBMC: 81 nTPM
- NK-cell: 78 nTPM
- MAIT T-cell: 78 nTPM
Brain region
- hypothalamus: 56 nTPM
- choroid plexus: 54 nTPM
- white matter: 53 nTPM
- pons: 51 nTPM
- spinal cord: 49 nTPM
- midbrain: 49 nTPM
ReferencesPubMed · IEDB
Publications for CCT6A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Chaperonin-containing T-complex Protein 1 Subunit ζ Serves as an Autoantigen Recognized by Human Vδ2 γδ T Cells in Autoimmune Diseases.
2016 · J Biol Chem · RCR 0.4 · 11 citations - Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1ζ Autoantibody as a Potential Biomarker in Thyroid Neoplasia.
2015 · J Clin Endocrinol Metab · RCR 0.2 · 5 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.26
- DepMap mean gene effect
- -1.66
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 14% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of establishment of protein localization to telomere
- positive regulation of protein localization to Cajal body
- positive regulation of telomerase RNA localization to Cajal body
- positive regulation of telomere maintenance via telomerase
- protein folding
- protein stabilization
Molecular functions
- ATP binding
- ATP hydrolysis activity
- ATP-dependent protein folding chaperone
- protein folding chaperone
- RNA binding
- unfolded protein binding
- WD40-repeat domain binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CCT6A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCT6A as an antibody target. Whether an autoantibody or antibody against CCT6A could matter depends on whether native CCT6A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCT6A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CCT6A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...